Your fact-checks will appear here
Hospital
Ivermectin in preclinical triple-negative breast cancer (TNBC) models acts through multiple, interconnected mechanisms that reshape the tumor immune microenvironment: it promotes immunogenic cancer ce...
Two U.S.-registered trials testing ivermectin in cancer patients are identifiable in recent reporting: a Phase I/II study combining ivermectin with the PD‑1 agonist balstilimab for metastatic triple‑n...
There is evidence of a small number of early‑phase clinical trials testing ivermectin in cancer patients, but they are limited in number, mostly based in the United States, and focused on combination ...
A single, actively recruiting clinical program testing ivermectin together with immune checkpoint blockade in cancer patients has emerged in the published record: a Phase I/II trial (ClinicalTrials.go...
Early anal cancer and hemorrhoids share key symptoms—bleeding, itching, lumps and pain—so distinguishing them by symptoms alone is unreliable; many sources say anal cancer often causes persistent or s...